Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-22-019646

Chief Financial Officer bought 31,746 shares at $3.15 ($100,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Celano Michael Chief Financial Officer 2022-09-16 Purchase +31,746 $3.15 $100,000 31,746 D
Open-market purchases · 31,746 sh · avg $3.15 · $100,000
Loading xslF345X03/form4.xml…